JP2010532766A5 - - Google Patents

Download PDF

Info

Publication number
JP2010532766A5
JP2010532766A5 JP2010515320A JP2010515320A JP2010532766A5 JP 2010532766 A5 JP2010532766 A5 JP 2010532766A5 JP 2010515320 A JP2010515320 A JP 2010515320A JP 2010515320 A JP2010515320 A JP 2010515320A JP 2010532766 A5 JP2010532766 A5 JP 2010532766A5
Authority
JP
Japan
Prior art keywords
composition
polypeptide
immune response
subject
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010515320A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010532766A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2008/001018 external-priority patent/WO2009006700A1/en
Publication of JP2010532766A publication Critical patent/JP2010532766A/ja
Publication of JP2010532766A5 publication Critical patent/JP2010532766A5/ja
Pending legal-status Critical Current

Links

JP2010515320A 2007-07-12 2008-07-11 バイオフィルムに対する免疫学的治療 Pending JP2010532766A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2007903787A AU2007903787A0 (en) 2007-07-12 Immunology treatment for biofilms
PCT/AU2008/001018 WO2009006700A1 (en) 2007-07-12 2008-07-11 Immunology treatment for biofilms

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013238416A Division JP2014058541A (ja) 2007-07-12 2013-11-19 バイオフィルムに対する免疫学的治療

Publications (2)

Publication Number Publication Date
JP2010532766A JP2010532766A (ja) 2010-10-14
JP2010532766A5 true JP2010532766A5 (enExample) 2011-08-25

Family

ID=40228121

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2010515320A Pending JP2010532766A (ja) 2007-07-12 2008-07-11 バイオフィルムに対する免疫学的治療
JP2013238416A Pending JP2014058541A (ja) 2007-07-12 2013-11-19 バイオフィルムに対する免疫学的治療

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013238416A Pending JP2014058541A (ja) 2007-07-12 2013-11-19 バイオフィルムに対する免疫学的治療

Country Status (10)

Country Link
US (2) US20100297179A1 (enExample)
EP (2) EP2604692A1 (enExample)
JP (2) JP2010532766A (enExample)
KR (1) KR20100071964A (enExample)
CN (2) CN101842486A (enExample)
AU (1) AU2008274907B2 (enExample)
CA (1) CA2693717A1 (enExample)
NZ (3) NZ582438A (enExample)
SG (1) SG182988A1 (enExample)
WO (1) WO2009006700A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO652897A0 (en) 1997-04-30 1997-05-29 University Of Melbourne, The Synthetic peptide constructs for the diagnosis and treatment of periodontitis
US8129500B2 (en) * 1997-12-10 2012-03-06 Csl Limited Porphyromonas gingivalis polypeptides and nucleotides
US20100092471A1 (en) 2006-06-27 2010-04-15 Oral Health Australia Pty Ltd Porphyromonas Gingivalis Polypeptides Useful in the Prevention of Periodontal Disease
ES2714008T3 (es) 2007-07-12 2019-05-24 Oral Health Australia Pty Ltd Tratamiento de biopelícula
CN107266582B (zh) 2008-08-29 2021-09-10 口腔健康澳洲私人有限公司 牙龈卟啉单胞菌感染的预防、治疗和诊断
BR112012002429A2 (pt) * 2009-08-02 2016-11-08 Sanofi Pasteur Ltd polipeptídeos de porphyromonas gingivalis
US8140041B2 (en) * 2009-08-27 2012-03-20 Mediatek Inc. Tunable capacitive device with linearization technique employed therein
CN105418758A (zh) * 2015-12-03 2016-03-23 沈阳惠民生物技术有限公司 一种抗牙周病抗体的制备方法及其应用
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
CN113005069B (zh) * 2021-01-28 2023-09-26 广东海洋大学 一种减毒鰤鱼诺卡氏菌及其制备方法和应用

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5210035A (en) * 1980-05-19 1993-05-11 Board Of Trustees Of Leland Stanford Jr. University Non-reventing live vaccines
US4735801A (en) * 1982-09-07 1988-04-05 Board Of Trustees Of Leland Stanford Jr. University Novel non-reverting salmonella live vaccines
US4837151A (en) 1980-05-19 1989-06-06 The Board Of Trustees Of The Leland Stanford Junior University, Stanford University Live vaccines comprising two mutations and foreign antigen
US4603112A (en) 1981-12-24 1986-07-29 Health Research, Incorporated Modified vaccinia virus
US5830710A (en) 1988-09-08 1998-11-03 University Of Florida Cloned porphyromonas gingivalis genes and probes for the detection of periodontal disease
WO1994027606A1 (en) 1993-05-28 1994-12-08 Unisearch Limited Method of treating helicobacter pylori infection
US5711937A (en) * 1993-06-28 1998-01-27 Lion Corporation Oral composition
US5523390A (en) * 1993-09-10 1996-06-04 University Of Georgia Research Foundation, Inc. Porphyromonas gingivalis arginine-specific proteinase
WO1995007286A1 (en) 1993-09-10 1995-03-16 University Of Georgia Research Foundation, Inc. Porphyromonas gingivalis arginine-specific proteinase coding sequences
US5475097A (en) * 1993-10-21 1995-12-12 University Of Georgia Research Foundation, Inc. Lysine-specific Porphyromonas gingivalis proteinase
US6017532A (en) * 1993-09-10 2000-01-25 University Of Georgia Research Foundation, Inc. Porphyromonas gingivalis arginine-specific proteinase
JPH0797395A (ja) 1993-09-28 1995-04-11 Kyowa Medex Co Ltd ポルフイロモナス・ジンジバリス線毛蛋白質の配列を含有するペプチド類及びその用途
US5948636A (en) 1994-03-29 1999-09-07 Kyowa Hakko Kogyo Co., Ltd. DNA and host cells encoding a cell surface protein of porphyromonas gingivalis
AUPN627595A0 (en) * 1995-10-30 1995-11-23 University Of Melbourne, The Diagnostics and treatments of periodontal disease
JP2000507245A (ja) * 1996-03-22 2000-06-13 ユニバーシティー オブ ジョージア リサーチ ファウンデーション，インコーポレイテッド Ｐｏｒｐｈｙｒｏｍｏｎａｓ ｇｉｎｇｉｖａｌｉｓペプチドを含む免疫原性組成物および方法
AUPN901296A0 (en) * 1996-03-29 1996-04-26 University Of Melbourne, The Porphyromonas gingivalis antigens for the diagnosis and treatment of periodontitis
US7341727B1 (en) * 1996-05-03 2008-03-11 Emergent Product Development Gaithersburg Inc. M. catarrhalis outer membrane protein-106 polypeptide, methods of eliciting an immune response comprising same
AUPO652897A0 (en) * 1997-04-30 1997-05-29 University Of Melbourne, The Synthetic peptide constructs for the diagnosis and treatment of periodontitis
AUPP083997A0 (en) * 1997-12-10 1998-01-08 Csl Limited Porphyromonas gingivalis nucleotides
ATE534742T1 (de) * 1997-12-10 2011-12-15 Csl Ltd Polypeptide und nukleinsäuren von phorphorymonas gingivalis
US8129500B2 (en) * 1997-12-10 2012-03-06 Csl Limited Porphyromonas gingivalis polypeptides and nucleotides
US6444799B1 (en) * 1997-12-31 2002-09-03 Csl Limited P. gingivalis polynucleotides and uses thereof
AUPP893999A0 (en) * 1999-03-01 1999-03-25 Csl Limited Synthetic peptides containing protective epitopes for the treatment and prevention of periodontitis associated with porphyromonas gingivalis
US7090973B1 (en) * 1999-04-09 2006-08-15 Oscient Pharmaceuticals Corporation Nucleic acid sequences relating to Bacteroides fragilis for diagnostics and therapeutics
GB9913437D0 (en) 1999-06-09 1999-08-11 Medical Res Council Fusion proteins
AUPQ485999A0 (en) * 1999-12-24 2000-02-03 Csl Limited P. gingivalis antigenic composition
AUPQ718200A0 (en) * 2000-04-28 2000-05-25 Csl Limited Porphyromonas gingivalis recombinant proteins and truncations
US6576226B1 (en) * 2000-11-17 2003-06-10 Gary R. Jernberg Local delivery of agents for disruption and inhibition of bacterial biofilm for treatment of periodontal disease
US20030083287A1 (en) 2000-11-30 2003-05-01 Burgess Nicola A. ginS
GB2381449A (en) 2001-10-31 2003-05-07 Smithkline Beecham Plc Oral hygiene compositions comprising an electron acceptor
JP2003192616A (ja) 2001-12-27 2003-07-09 Univ Nihon 歯周病用ｄｎａワクチン
JP2003286191A (ja) 2002-03-27 2003-10-07 Univ Nihon 歯周病用粘膜免疫ワクチン
JPWO2004083425A1 (ja) 2003-03-17 2006-06-22 麒麟麦酒株式会社 歯周病治療剤
AU2004266213A1 (en) * 2003-08-15 2005-03-03 University Of Florida Identification of porphyromonas gingivalis virulence polynucleotides for diagnosis, treatment, and monitoring of periodontal diseases
WO2005076010A2 (en) * 2004-02-06 2005-08-18 Council Of Scientific And Industrial Research Computational method for identifying adhesin and adhesin-like proteins of therapeutic potential
EP1799705A4 (en) * 2004-09-23 2008-11-05 Univ Melbourne Antigenic complex for the diagnosis and treatment of porphyromonas gingivalis infection
WO2008016385A2 (en) * 2006-01-20 2008-02-07 The University Of Washington Deacylase polypeptides, deacylase polynucleotides, and methods of use thereof
US20100092471A1 (en) * 2006-06-27 2010-04-15 Oral Health Australia Pty Ltd Porphyromonas Gingivalis Polypeptides Useful in the Prevention of Periodontal Disease
WO2008124646A2 (en) 2007-04-06 2008-10-16 The Government Of The U.S.A, As Represented By The Secretary, Dept. Of Health And Human Services Use of amyloid proteins as vaccine scaffolds
ES2714008T3 (es) * 2007-07-12 2019-05-24 Oral Health Australia Pty Ltd Tratamiento de biopelícula
US20110104179A1 (en) * 2009-06-19 2011-05-05 Oral Health Australia Pty Ltd Protease inhibitory peptides

Similar Documents

Publication Publication Date Title
JP2010532766A5 (enExample)
JP2014058541A5 (enExample)
RU2017104529A (ru) Композиции neisseria meningitidis и способы их применения
JP2015514395A5 (enExample)
EA202090053A3 (ru) Способы и композиции для лечения неэффективного эритропоэза
IN2014KN01714A (enExample)
PE20142330A1 (es) Vacuna de peptido ch3 de ige
HRP20191291T1 (hr) Imunogeni pripravak
MX360208B (es) Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
MX360211B (es) Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
ES2585328T3 (es) Variantes no lipidadas de antígenos ORF2086 de Neisseria meningitidis
JP2007509067A5 (enExample)
EP4421177A3 (en) Prefusion rsv f proteins and their use
JP2013172734A5 (enExample)
WO2011103453A3 (en) Vaccines for use in the prophylaxis and treatment of influenza virus disease
UA110806C2 (uk) Мікобактеріальна антигенна композиція
ES2627330T3 (es) Uso de JAZ5a para mejorar la resistencia a la sequía en una planta
AR081809A1 (es) Composiciones farmaceuticas que comprenden un polipeptido que comprende al menos un motivo cxxc y antigenos heterologos y usos de las mismas
NZ605037A (en) Immunology treatment for biofilms
WO2008124646A3 (en) Use of amyloid proteins as vaccine scaffolds
CL2012003458A1 (es) Vector que comprende un polipeptido antigénico de campylobacter; composicion farmacéutica que comprende dicho vector; uso del vector para mejorar respuesta inmune del sujeto al polipéptido antigénico.
CL2011002994A1 (es) Construccion de proteina que comprende polipeptido casb7439; composicion inmunogenica que comprende dicha construccion; uso de la composicion porque sirve para inducir respuesta inmunitaria al casb7439 en un animal.
NZ594268A (en) Grass peptides for vaccine
NZ704188A (en) Attenuated swine influenza vaccines and methods of making and use thereof
JP2017517561A5 (enExample)